KRAS and serous cystadenoma: This information of genetics is important because it allows physicians to reassure patients (diagnosed with serous cystadenoma) that their condition is not implicated with mutations that could cause other disease states such as colorectal cancer (associated with KRAS) [5] and melanoma (associated with BRAF) [6].